DIACEUTICS PLC – Diaceutics And Pcc Launch Ngs Concordance Study
RNS Number : 0073R Diaceutics PLC 20 August 2026 RNS Reach Diaceutics PLC Diaceutics and PCC launch NGS
RNS Number : 0073R Diaceutics PLC 20 August 2026 RNS Reach Diaceutics PLC Diaceutics and PCC launch NGS
RNS Number : 0994Z Diaceutics PLC 07 April 2026 Diaceutics PLC BLOCK LISTING RETURN New York, Belfast and
Diaceutics PLC (AIM: DXRX), a diagnostic commercialisation company for precision testing, reports its audited results for the year-ended 31 December 2020.
Diaceutics PLC (AIM: DXRX) announces a trading update for the year ended 31 December 2020.
Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces a trading update for the six months ended 30 June 2020.
Diaceutics PLC the “Company” or the “Group”, a diagnostic commercialisation company for precision testing, is pleased to report its audited results for the year ended 31 December 2019.
Diaceutics PLC (AIM: DXRX), a provider of data analytics and implementation services to the global pharmaceutical industry, announces a trading update for the year ended 31 December 2019.
Diaceutics PLC (AIM: DXRX), a provider of data analytics and implementation services to the global pharmaceutical industry, announces its unaudited interim results for the six months ended 30 June 2019. The Company remains well positioned within its key markets, underpinned by a strong sales performance.
Diaceutics PLC (AIM: DXRX), a provider of data analytics and implementation services to the global pharmaceutical industry, announces a trading update for the six months ended 30 June 2019.